Simulations Plus, Inc develops drug discovery and development software for mechanistic modeling and simulation, and machine-learning-based prediction of properties of molecules from their structure worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments that measure the rate of dissolution of the drug and additives in a dosage form; and MembranePlus, which simulates laboratory experiments.
Read More…
Industry, Sector and Symbol
Industry Computer integrated systems design
Sub-IndustryN/A
SectorComputer and Technology
Phone661-723-7723
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$29.67 million
Profitability
Miscellaneous
Employees93
Next Earnings Date1/8/2020 (Estimated)
OptionableOptionable
Simulations Plus (NASDAQ:SLP) Frequently Asked Questions
What is Simulations Plus' stock symbol?
Simulations Plus trades on the NASDAQ under the ticker symbol "SLP."
How often does Simulations Plus pay dividends? What is the dividend yield for Simulations Plus?
Simulations Plus announced a quarterly dividend on Monday, October 14th. Investors of record on Friday, October 25th will be paid a dividend of $0.06 per share on Friday, November 1st. This represents a $0.24 annualized dividend and a dividend yield of 0.71%. The ex-dividend date of this dividend is Thursday, October 24th. View Simulations Plus' Dividend History.
How were Simulations Plus' earnings last quarter?
Simulations Plus, Inc. (NASDAQ:SLP) released its quarterly earnings data on Wednesday, November, 13th. The technology company reported $0.11 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.09 by $0.02. The technology company had revenue of $8.03 million for the quarter, compared to the consensus estimate of $7.52 million. Simulations Plus had a net margin of 24.09% and a return on equity of 23.48%. View Simulations Plus' Earnings History.
When is Simulations Plus' next earnings date?
What is the consensus analysts' recommendation for Simulations Plus?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Simulations Plus in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Simulations Plus.
Has Simulations Plus been receiving favorable news coverage?
Media coverage about SLP stock has trended somewhat negative recently, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Simulations Plus earned a coverage optimism score of -1.4 on InfoTrie's scale. They also gave headlines about the technology company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Simulations Plus.
Are investors shorting Simulations Plus?
Simulations Plus saw a increase in short interest in the month of October. As of October 31st, there was short interest totalling 984,300 shares, an increase of 29.2% from the September 30th total of 762,100 shares. Based on an average daily volume of 119,400 shares, the short-interest ratio is presently 8.2 days. Currently, 8.1% of the company's stock are short sold. View Simulations Plus' Current Options Chain.
Who are some of Simulations Plus' key competitors?
Some companies that are related to Simulations Plus include NetScout Systems (NTCT), Allscripts Healthcare Solutions (MDRX), Sykes Enterprises (SYKE), Ebix (EBIX), Nextgen Healthcare (NXGN), Onespan (OSPN), Unisys (UIS), Tufin Software Technologies (TUFN), Agilysys (AGYS), Digimarc (DMRC), Ribbon Communications (RBBN), Asure Software (ASUR), Travelzoo (TZOO), Borqs Technologies (BRQS) and CSP (CSPI).
What other stocks do shareholders of Simulations Plus own?
Who are Simulations Plus' key executives?
Simulations Plus' management team includes the folowing people:
- Mr. Walter S. Woltosz, Co-Founder & Chairman (Age 74)
- Mr. Shawn M. O'Connor, Chief Exec. Officer (Age 59)
- Mr. John R. Kneisel, Chief Financial Officer (Age 61)
- Dr. Thaddeus Henry Grasela Jr., Pharm.D., PharmD, Ph.D., Pres Buffalo Division, Director of Simulations Plus & Director (Age 65)
- Mr. John Anthony DiBella, Pres of the Lancaster Division (Age 39)
Who are Simulations Plus' major shareholders?
Simulations Plus' stock is owned by a number of of institutional and retail investors. Top institutional investors include Russell Investments Group Ltd. (1.04%), Congress Asset Management Co. MA (0.42%), California Public Employees Retirement System (0.33%), SG Americas Securities LLC (0.29%), Creative Planning (0.14%) and Strs Ohio (0.10%). Company insiders that own Simulations Plus stock include David L Ralph, John Kenneth Paglia, John Robert Kneisel and Walter S Woltosz. View Institutional Ownership Trends for Simulations Plus.
Which major investors are selling Simulations Plus stock?
SLP stock was sold by a variety of institutional investors in the last quarter, including Campbell & CO Investment Adviser LLC, Strs Ohio, Connors Investor Services Inc., Envestnet Asset Management Inc. and Oppenheimer Asset Management Inc.. Company insiders that have sold Simulations Plus company stock in the last year include David L Ralph, John Kenneth Paglia and Walter S Woltosz. View Insider Buying and Selling for Simulations Plus.
Which major investors are buying Simulations Plus stock?
SLP stock was bought by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Congress Asset Management Co. MA, SG Americas Securities LLC, Creative Planning, California Public Employees Retirement System, Chicago Equity Partners LLC, Navellier & Associates Inc and Cavalier Investments LLC. View Insider Buying and Selling for Simulations Plus.
How do I buy shares of Simulations Plus?
Shares of SLP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Simulations Plus' stock price today?
One share of SLP stock can currently be purchased for approximately $33.67.
How big of a company is Simulations Plus?
Simulations Plus has a market capitalization of $590.24 million and generates $29.67 million in revenue each year. The technology company earns $8.93 million in net income (profit) each year or $0.50 on an earnings per share basis. Simulations Plus employs 93 workers across the globe.View Additional Information About Simulations Plus.
What is Simulations Plus' official website?
How can I contact Simulations Plus?
Simulations Plus' mailing address is 42505 10TH STREET WEST, LANCASTER CA, 93534. The technology company can be reached via phone at 661-723-7723 or via email at [email protected]
MarketBeat Community Rating for Simulations Plus (NASDAQ SLP)
MarketBeat's community ratings are surveys of what our community members think about Simulations Plus and other stocks. Vote "Outperform" if you believe SLP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SLP will underperform the S&P 500 over the long term. You may vote once every thirty days.
